Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial
- PMID: 37400432
- PMCID: PMC10318050
- DOI: 10.1038/s41398-023-02537-9
Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial
Abstract
Here, we investigated the brain functional connectivity (FC) changes following a novel accelerated theta burst stimulation protocol known as Stanford Neuromodulation Therapy (SNT) which demonstrated significant antidepressant efficacy in treatment-resistant depression (TRD). In a sample of 24 patients (12 active and 12 sham), active stimulation was associated with significant pre- and post-treatment modulation of three FC pairs, involving the default mode network (DMN), amygdala, salience network (SN) and striatum. The most robust finding was the SNT effect on amygdala-DMN FC (group*time interaction F(1,22) = 14.89, p < 0.001). This FC change correlated with improvement in depressive symptoms (rho (Spearman) = -0.45, df = 22, p = 0.026). The post-treatment FC pattern showed a change in the direction of the healthy control group and was sustained at the one-month follow-up. These results are consistent with amygdala-DMN connectivity dysfunction as an underlying mechanism of TRD and bring us closer to the goal of developing imaging biomarkers for TMS treatment optimization.Trial registration: ClinicalTrials.gov NCT03068715.
© 2023. The Author(s).
Conflict of interest statement
Dr. Williams is a named inventor on Stanford-owned intellectual property relating to accelerated TMS pulse pattern sequences and neuroimaging-based TMS targeting; he has served on scientific advisory boards for Otsuka, NeuraWell, Magnus Medical, and Nooma as a paid advisor; and he has equity/stock options in Magnus Medical, NeuraWell, and Nooma. All other authors declare no conflicts of interest.
Figures
Similar articles
-
Increased anti-correlation between the left dorsolateral prefrontal cortex and the default mode network following Stanford Neuromodulation Therapy (SNT): analysis of a double-blinded, randomized, sham-controlled trial.Npj Ment Health Res. 2024 Jul 6;3(1):35. doi: 10.1038/s44184-024-00073-y. Npj Ment Health Res. 2024. PMID: 38971869 Free PMC article.
-
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial.Am J Psychiatry. 2022 Feb;179(2):132-141. doi: 10.1176/appi.ajp.2021.20101429. Epub 2021 Oct 29. Am J Psychiatry. 2022. PMID: 34711062 Clinical Trial.
-
Distinct patterns of functional brain network integration between treatment-resistant depression and non treatment-resistant depression: A resting-state functional magnetic resonance imaging study.Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110621. doi: 10.1016/j.pnpbp.2022.110621. Epub 2022 Aug 27. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 36031163
-
Dysregulation within the salience network and default mode network in hyperthyroid patients: a follow-up resting-state functional MRI study.Brain Imaging Behav. 2020 Feb;14(1):30-41. doi: 10.1007/s11682-018-9961-6. Brain Imaging Behav. 2020. PMID: 30259292 Review.
-
The neurobiology of treatment-resistant depression: A systematic review of neuroimaging studies.Neurosci Biobehav Rev. 2022 Jan;132:433-448. doi: 10.1016/j.neubiorev.2021.12.008. Epub 2021 Dec 7. Neurosci Biobehav Rev. 2022. PMID: 34890601 Review.
Cited by
-
Theta burst stimulation for depression: a systematic review and network and pairwise meta-analysis.Mol Psychiatry. 2024 Dec;29(12):3893-3899. doi: 10.1038/s41380-024-02630-5. Epub 2024 Jun 6. Mol Psychiatry. 2024. PMID: 38844532 Free PMC article.
-
Beyond the serotonin deficit hypothesis: communicating a neuroplasticity framework of major depressive disorder.Mol Psychiatry. 2024 Dec;29(12):3802-3813. doi: 10.1038/s41380-024-02625-2. Epub 2024 May 31. Mol Psychiatry. 2024. PMID: 38816586 Review.
-
Early differences in lassitude predicts outcomes in Stanford Neuromodulation Therapy for difficult to treat depression.Npj Ment Health Res. 2024 Oct 28;3(1):49. doi: 10.1038/s44184-024-00099-2. Npj Ment Health Res. 2024. PMID: 39468255 Free PMC article.
-
Regional cortical brain volumes at treatment entry relates to post treatment WHO risk drinking levels in those with alcohol use disorder.Drug Alcohol Depend. 2024 Feb 1;255:111082. doi: 10.1016/j.drugalcdep.2024.111082. Epub 2024 Jan 5. Drug Alcohol Depend. 2024. PMID: 38219355 Free PMC article.
-
The antidepressant effect of intermittent theta burst stimulation (iTBS): study protocol for a randomized double-blind sham-controlled trial.Trials. 2023 Oct 2;24(1):627. doi: 10.1186/s13063-023-07674-6. Trials. 2023. PMID: 37784199 Free PMC article.
References
-
- Zhdanava M, Pilon D, Ghelerter I, Chow W, Joshi K, Lefebvre P, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry [Internet] 2021;82:20m13699. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
